LEADER 01918oam  2200469 a 450 
001 9910702295003321
005 20130626165025.0
035   $a(CKB)5470000002425194
035   $a(OCoLC)812542200
035   $a(EXLCZ)995470000002425194
100   $a20121011d1978      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aBioassay of dixathion for possible carcinogenicity$b[electronic resource] /$fCarcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
210  1$aBethesda, Md. :$cU. S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health,$d1978.
215   $a1 online resource (101 unnumbered pages) $cillustrations
225 1 $aNational Cancer Institute carcinogenesis technical report series ;$vno. 125
225 1 $aDHEW publication ;$vno. (NIH) 78-1380.
300   $aTitle from title screen (viewed on Oct. 11, 2012).
300   $a"CAS no. 78-34-2."
300   $a"NCI-CG-TR-125."
300   $aConducted for the Carcinogenesis Testing Program, National Cancer Institute, by Hazleton Laboratories America, inc., Vienna, Va.
606   $aCarcinogenicity testing
606   $aInsecticides$xToxicology
615  0$aCarcinogenicity testing.
615  0$aInsecticides$xToxicology.
712 02$aHazleton Laboratories America.
712 02$aNational Institutes of Health (U.S.)
712 02$aCarcinogenesis Testing Program (U.S.)
712 02$aNational Cancer Institute (U.S.).$bDivision of Cancer Cause and Prevention.
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bOCLCQ
801  2$bGPO
906   $aBOOK
912   $a9910702295003321
996   $aBioassay of dixathion for possible carcinogenicity$93156313
997   $aUNINA